S3-E22 – NASH Tsunami previews the 5th Global NASH Congress
Ian Rowe and Rachel Zayas join the Surfers to help Surfing the NASH Tsunami preview the 5th Global NASH Congress.
April 28, 2022
Ian Rowe and Rachel Zayas join the Surfers to help Surfing the NASH Tsunami preview the 5th Global NASH Congress.
Conference founders and directors Jeffrey Lazarus and Jörn Schattenberg join Roger Green to preview the inaugural Innovations in NAFLD Care 2022 conference, scheduled for May 6 and 7 In Barcelona and on-line.
This Episode is Sponsored by Madrigal Pharmaceuticals: CLDF opted for a Liver Connect program that featured conversations between sizable groups of experts instead of lengthy scientific presentations. How well did it work for panelists?
This Episode is Sponsored by Madrigal Pharmaceuticals: What Can We Learn About Health Disparities In NASH Epidemiology and Treatment From the Content of NASH Connect?
This Episode is Sponsored by Madrigal Pharmaceuticals: What does CLDF President Zobair Younossi have to say about Liver Connect, NASH Connect, and the needs of the Fatty Liver community?
This Episode Is Sponsored By Madrigal Pharmaceuticals. What Insights About NASH and NAFLD Emerged From the Chronic Liver Disease Foundation’s 2nd Annual Liver Connect and NASH Connect?
Jeff Lazarus And Jörn Schattenberg of the Innovations in NAFLD Care 2022 Series join the Surfers to consider innovative elements for a program like this along with the outcomes they would like these programs to produce.
Jeff Lazarus And Jörn Schattenberg of the Innovations in NAFLD Care 2022 Series join the Surfers to discuss the structural healthcare issues that are shaping the Fatty Liver pandemic and why education is such an important part of the solution.
Co-chairs Jeff Lazarus and Jörn Schattenberg of the Innovations in NAFLD Care 2022 Series join the Surfers to review the initiative’s key elements and patient awareness goals.
Co-chairs of the Innovations in NAFLD Care 2022 initiative join the Surfers to review the initiative’s goals and agenda.